Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024.
Saved in:
| Title: | Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024. |
|---|---|
| Alternate Title: | Hacia un abordaje integral de las infecciones pulmonares. Claves desde la Sexta Reunión Anual de Expertos Españoles de 2024. |
| Authors: | Rodriguez-Leal, Cristobal M.1,2, González-Corralejo, Carlos3,4, Javier-Candel, Francisco2,4,5 franciscojavier.candel@salud.madrid.org, Salavert, Miguel4,6 |
| Source: | Revista Española de Quimioterapia. jun2025, Vol. 38 Issue 3, p152-186. 35p. |
| Subjects: | COMMUNITY-acquired pneumonia, MEDICAL personnel, INTENSIVE care units, LUNG infections, OLDER patients |
| Abstract (English): | Pneumonia is the leading cause of death from infection in the developed world. In recent years, researchers and healthcare professionals have worked extensively to reduce this burden. Prevention is better than cure, and significant advances have been made in areas such as vaccination and the prevention of nosocomial pneumonia in intensive care units. Comprehensive surveillance programmes and new diagnostic methods have been developed to assess trends in this disease and to identify the infectious agents involved. Clinical presentation can be challenging in elderly patients or those with certain comorbidities, prompting new studies in these populations to address these issues. Correct and early management of severe communityacquired pneumonia represents a major opportunity to reduce its associated mortality. Although fungal pathogens are an uncommon cause of lung infection, they are associated with high morbidity and mortality, highlighting the need for new approaches. Finally, new drugs are available for the treatment of pneumonia, and a thorough understanding of them is key to ensuring their correct use, particularly to combat multi-resistance. To provide an update on these points, a multidisciplinary team of Spanish experts convened at the Sixth Annual Meeting of Pneumonia Day, under the scientific sponsorship of GEIPC-SEIMC. This paper reflects the information shared at this meeting, offering the latest insights on these topics and supporting a holistic approach to pneumonia management. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): | La neumonía es la principal causa de muerte por infección en el mundo desarrollado. En los últimos años, investigadores y profesionales de la salud han trabajado intensamente para reducir esta carga. Más vale prevenir que curar, así que se han invertido importantes esfuerzos en ámbitos como la vacunación y la prevención de la neumonía nosocomial en las unidades de cuidados intensivos. Se han desarrollado programas de vigilancia integral y nuevos métodos de diagnóstico para evaluar las tendencias de esta enfermedad e identificar los agentes infecciosos implicados. La presentación clínica puede ser desafiante en pacientes de edad avanzada o con ciertas comorbilidades, lo que ha impulsado la realización de nuevos estudios en estas poblaciones para abordar estos problemas. El tratamiento correcto y precoz de la neumonía adquirida en la comunidad grave representa una gran oportunidad para reducir su mortalidad asociada. Aunque los hongos son una causa infrecuente de infección pulmonar, se asocian a una elevada morbilidad y mortalidad, lo que resalta la necesidad de nuevos enfoques diagnósticos y terapéuticos. Por último, se dispone de nuevos fármacos para el tratamiento de la neumonía, y un buen conocimiento de estos es la clave para su correcta utilización, especialmente para combatir la multirresistencia. Para actualizar estos temas, un equipo multidisciplinar de expertos españoles se reunió en la VI Jornada Anual de Neumonía, bajo el auspicio científico del GEIPC-SEIMC. Este documento refleja la información compartida en esta reunión, en la que se presentan los últimos avances sobre estos temas y se ofrece información relevante para un abordaje integral de la neumonía. [ABSTRACT FROM AUTHOR] |
| Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | MedicLatina |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: lth DbLabel: MedicLatina An: 185439411 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024. – Name: TitleAlt Label: Alternate Title Group: TiAlt Data: Hacia un abordaje integral de las infecciones pulmonares. Claves desde la Sexta Reunión Anual de Expertos Españoles de 2024. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Rodriguez-Leal%2C+Cristobal+M%2E%22">Rodriguez-Leal, Cristobal M.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22González-Corralejo%2C+Carlos%22">González-Corralejo, Carlos</searchLink><relatesTo>3,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Javier-Candel%2C+Francisco%22">Javier-Candel, Francisco</searchLink><relatesTo>2,4,5</relatesTo><i> franciscojavier.candel@salud.madrid.org</i><br /><searchLink fieldCode="AR" term="%22Salavert%2C+Miguel%22">Salavert, Miguel</searchLink><relatesTo>4,6</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Revista+Española+de+Quimioterapia%22">Revista Española de Quimioterapia</searchLink>. jun2025, Vol. 38 Issue 3, p152-186. 35p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22COMMUNITY-acquired+pneumonia%22">COMMUNITY-acquired pneumonia</searchLink><br /><searchLink fieldCode="DE" term="%22MEDICAL+personnel%22">MEDICAL personnel</searchLink><br /><searchLink fieldCode="DE" term="%22INTENSIVE+care+units%22">INTENSIVE care units</searchLink><br /><searchLink fieldCode="DE" term="%22LUNG+infections%22">LUNG infections</searchLink><br /><searchLink fieldCode="DE" term="%22OLDER+patients%22">OLDER patients</searchLink> – Name: Abstract Label: Abstract (English) Group: Ab Data: Pneumonia is the leading cause of death from infection in the developed world. In recent years, researchers and healthcare professionals have worked extensively to reduce this burden. Prevention is better than cure, and significant advances have been made in areas such as vaccination and the prevention of nosocomial pneumonia in intensive care units. Comprehensive surveillance programmes and new diagnostic methods have been developed to assess trends in this disease and to identify the infectious agents involved. Clinical presentation can be challenging in elderly patients or those with certain comorbidities, prompting new studies in these populations to address these issues. Correct and early management of severe communityacquired pneumonia represents a major opportunity to reduce its associated mortality. Although fungal pathogens are an uncommon cause of lung infection, they are associated with high morbidity and mortality, highlighting the need for new approaches. Finally, new drugs are available for the treatment of pneumonia, and a thorough understanding of them is key to ensuring their correct use, particularly to combat multi-resistance. To provide an update on these points, a multidisciplinary team of Spanish experts convened at the Sixth Annual Meeting of Pneumonia Day, under the scientific sponsorship of GEIPC-SEIMC. This paper reflects the information shared at this meeting, offering the latest insights on these topics and supporting a holistic approach to pneumonia management. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Abstract (Spanish) Group: Ab Data: La neumonía es la principal causa de muerte por infección en el mundo desarrollado. En los últimos años, investigadores y profesionales de la salud han trabajado intensamente para reducir esta carga. Más vale prevenir que curar, así que se han invertido importantes esfuerzos en ámbitos como la vacunación y la prevención de la neumonía nosocomial en las unidades de cuidados intensivos. Se han desarrollado programas de vigilancia integral y nuevos métodos de diagnóstico para evaluar las tendencias de esta enfermedad e identificar los agentes infecciosos implicados. La presentación clínica puede ser desafiante en pacientes de edad avanzada o con ciertas comorbilidades, lo que ha impulsado la realización de nuevos estudios en estas poblaciones para abordar estos problemas. El tratamiento correcto y precoz de la neumonía adquirida en la comunidad grave representa una gran oportunidad para reducir su mortalidad asociada. Aunque los hongos son una causa infrecuente de infección pulmonar, se asocian a una elevada morbilidad y mortalidad, lo que resalta la necesidad de nuevos enfoques diagnósticos y terapéuticos. Por último, se dispone de nuevos fármacos para el tratamiento de la neumonía, y un buen conocimiento de estos es la clave para su correcta utilización, especialmente para combatir la multirresistencia. Para actualizar estos temas, un equipo multidisciplinar de expertos españoles se reunió en la VI Jornada Anual de Neumonía, bajo el auspicio científico del GEIPC-SEIMC. Este documento refleja la información compartida en esta reunión, en la que se presentan los últimos avances sobre estos temas y se ofrece información relevante para un abordaje integral de la neumonía. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=185439411 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.37201/req/017.2025 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 35 StartPage: 152 Subjects: – SubjectFull: COMMUNITY-acquired pneumonia Type: general – SubjectFull: MEDICAL personnel Type: general – SubjectFull: INTENSIVE care units Type: general – SubjectFull: LUNG infections Type: general – SubjectFull: OLDER patients Type: general Titles: – TitleFull: Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rodriguez-Leal, Cristobal M. – PersonEntity: Name: NameFull: González-Corralejo, Carlos – PersonEntity: Name: NameFull: Javier-Candel, Francisco – PersonEntity: Name: NameFull: Salavert, Miguel IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: jun2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 02143429 Numbering: – Type: volume Value: 38 – Type: issue Value: 3 Titles: – TitleFull: Revista Española de Quimioterapia Type: main |
| ResultId | 1 |
